How can biomarkers help us better define Parkinson's disease?

被引：0
|
作者：
Mollenhauer, B. [1 ,2 ]
机构：
[1] Paracelsus Elena Klin, Kassel, Germany
[2] Univ Med Ctr, Dept Neurol, Gottingen, Germany
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2022年 / 29卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
SYMP01-1
引用
收藏
页码：6 / 6
页数：1
相关论文
共 50 条
  • [1] Can Biomarkers Help the Early Diagnosis of Parkinson's Disease?
    Weidong Le
    Jie Dong
    Song Li
    Amos D.Korczyn
    Neuroscience Bulletin, 2017, 33 (05) : 535 - 542
  • [2] Can Biomarkers Help the Early Diagnosis of Parkinson’s Disease?
    Weidong Le
    Jie Dong
    Song Li
    Amos D. Korczyn
    Neuroscience Bulletin, 2017, 33 : 535 - 542
  • [3] Can Biomarkers Help the Early Diagnosis of Parkinson's Disease?
    Le, Weidong
    Dong, Jie
    Li, Song
    Korczyn, Amos D.
    NEUROSCIENCE BULLETIN, 2017, 33 (05) : 535 - 542
  • [4] Current and future clinical utilities of Parkinson's disease and dementia biomarkers: can they help us conquer the disease?
    Ho, Gilbert
    Takamatsu, Yoshiki
    Waragai, Masaaki
    Wada, Ryoko
    Sugama, Shuei
    Takenouchi, Takato
    Fujita, Masayo
    Ali, Alysha
    Hsieh, Mindy Hsin-I
    Hashimoto, Makoto
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2019, 19 (11) : 1149 - 1161
  • [5] Can biomarkers help us to better diagnose and manage sepsis?
    Schuetz, Philipp
    Plebani, Mario
    DIAGNOSIS, 2015, 2 (02) : 81 - 87
  • [6] Biomarkers in Down syndrome can help us understand Alzheimer's disease
    Head, Elizabeth
    Ances, Beau
    LANCET, 2020, 395 (10242): : 1951 - 1953
  • [7] What can biomarkers tell us about cognition in Parkinson's disease?
    Mollenhauer, Brit
    Rochester, Lynn
    Chen-Plotkin, Alice
    Brooks, David
    MOVEMENT DISORDERS, 2014, 29 (05) : 622 - 633
  • [8] Using 'omics' to define pathogenesis and biomarkers of Parkinson's disease
    Caudle, W. Michael
    Bammler, Theo K.
    Lin, Yvonne
    Pan, Sheng
    Zhang, Jing
    EXPERT REVIEW OF NEUROTHERAPEUTICS, 2010, 10 (06) : 925 - 942
  • [9] How can behavioural science help us design better trials?
    Katie Gillies
    Jamie Brehaut
    Taylor Coffey
    Eilidh M. Duncan
    Jill J. Francis
    Spencer P. Hey
    Justin Presseau
    Charles Weijer
    Marion K. Campbell
    Trials, 22
  • [10] Biomarkers for Parkinson's Disease: How Good Are They?
    Li, Tianbai
    Le, Weidong
    NEUROSCIENCE BULLETIN, 2020, 36 (02) : 183 - 194
12345